Addex Therapeutics Ltd
SIX:ADXN
Addex Therapeutics Ltd
SIX:ADXN
Price:
0.071 CHF
-3.79%
Updated:
May 15, 2024
Addex Therapeutics Ltd
Selling, General & Administrative
|
Addex Therapeutics Ltd
Selling, General & Administrative Peer Comparison
Comparables:
ADCT
ACIU
CRSP
BSLN
IDIA
Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Addex Therapeutics Ltd
SIX:ADXN
|
Selling, General & Administrative
-CHf5m
|
CAGR 3-Years
5%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
|
ADC Therapeutics SA
NYSE:ADCT
|
Selling, General & Administrative
-$105.9m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-65%
|
CAGR 10-Years
N/A
|
|
|
AC Immune SA
NASDAQ:ACIU
|
Selling, General & Administrative
-CHf10.6m
|
CAGR 3-Years
2%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
|
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
Selling, General & Administrative
-$206.8m
|
CAGR 3-Years
-30%
|
CAGR 5-Years
-31%
|
CAGR 10-Years
N/A
|
|
|
Basilea Pharmaceutica AG
SIX:BSLN
|
Selling, General & Administrative
-CHf33.8m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-5%
|
|
|
Idorsia Ltd
SIX:IDIA
|
Selling, General & Administrative
-CHf504m
|
CAGR 3-Years
-100%
|
CAGR 5-Years
-75%
|
CAGR 10-Years
N/A
|
See Also
What is Addex Therapeutics Ltd's Selling, General & Administrative?
Selling, General & Administrative
-5m
CHF
-5m
CHF
Based on the financial report for Dec 31, 2023, Addex Therapeutics Ltd's Selling, General & Administrative amounts to -5m CHF.
What is Addex Therapeutics Ltd's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 5Y
-9%
-9%
Over the last year, the Selling, General & Administrative growth was 32%. The average annual Selling, General & Administrative growth rates for Addex Therapeutics Ltd have been 5% over the past three years , -9% over the past five years .
You don't have any saved screeners yet
